TIAA CREF Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $987K | Buy |
38,396
+7,589
| +25% | +$195K | ﹤0.01% | 2323 |
|
2018
Q4 | $709K | Sell |
30,807
-233
| -0.8% | -$5.36K | ﹤0.01% | 2425 |
|
2018
Q3 | $996K | Sell |
31,040
-2,446
| -7% | -$78.5K | ﹤0.01% | 2420 |
|
2018
Q2 | $948K | Buy |
33,486
+802
| +2% | +$22.7K | ﹤0.01% | 2514 |
|
2018
Q1 | $1.16M | Sell |
32,684
-519
| -2% | -$18.4K | ﹤0.01% | 2362 |
|
2017
Q4 | $1.29M | Buy |
33,203
+2,689
| +9% | +$104K | ﹤0.01% | 2343 |
|
2017
Q3 | $775K | Sell |
30,514
-16,801
| -36% | -$427K | ﹤0.01% | 2639 |
|
2017
Q2 | $1.29M | Buy |
47,315
+2,260
| +5% | +$61.7K | ﹤0.01% | 2421 |
|
2017
Q1 | $1.49M | Sell |
45,055
-3,329
| -7% | -$110K | ﹤0.01% | 2308 |
|
2016
Q4 | $1.15M | Sell |
48,384
-27,159
| -36% | -$647K | ﹤0.01% | 2452 |
|
2016
Q3 | $2.77K | Buy |
75,543
+2,689
| +4% | +$99 | ﹤0.01% | 1996 |
|
2016
Q2 | $1.63M | Sell |
72,854
-11,297
| -13% | -$252K | ﹤0.01% | 2248 |
|
2016
Q1 | $1.75M | Buy |
84,151
+15,015
| +22% | +$312K | ﹤0.01% | 2157 |
|
2015
Q4 | $2.1M | Buy |
69,136
+6,130
| +10% | +$186K | ﹤0.01% | 2115 |
|
2015
Q3 | $1.56M | Sell |
63,006
-6,350
| -9% | -$157K | ﹤0.01% | 2298 |
|
2015
Q2 | $2.23M | Buy |
69,356
+32,931
| +90% | +$1.06M | ﹤0.01% | 2236 |
|
2015
Q1 | $1.3M | Hold |
36,425
| – | – | ﹤0.01% | 2478 |
|
2014
Q4 | $827K | Sell |
36,425
-1,903
| -5% | -$43.2K | ﹤0.01% | 2759 |
|
2014
Q3 | $744K | Sell |
38,328
-1,055
| -3% | -$20.5K | ﹤0.01% | 2799 |
|
2014
Q2 | $1.43M | Buy |
39,383
+926
| +2% | +$33.6K | ﹤0.01% | 2500 |
|
2014
Q1 | $1.49M | Sell |
38,457
-1,084
| -3% | -$42.1K | ﹤0.01% | 2411 |
|
2013
Q4 | $1.13M | Sell |
39,541
-1,960
| -5% | -$55.9K | ﹤0.01% | 2597 |
|
2013
Q3 | $1.49M | Sell |
41,501
-9,226
| -18% | -$330K | ﹤0.01% | 2390 |
|
2013
Q2 | $1.69M | Buy |
+50,727
| New | +$1.69M | ﹤0.01% | 2272 |
|